ILMN

#592
Illumina Inc
129.13 USD
+1.71%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
126.49
129.13
Rango anual
69.88
155.47
Cambio diario
+1.71%
Variación mensual
+7.63%
Variación en los últimos 6 meses
+42.51%
Cambio anual
+72.31%
Cierres anteriores
126.96
Abrir
126.79
Bid
Ask
Mínimo
126.49
High
129.13
Volumen
69
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 19.74 B
  • Employee 8 650
  • Founded 1998
  • CEO Jacob Thaysen
  • Website www.illumina.com
  • Headquarter Delaware, United States
  • FIGI BBG000DSMS70
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
24.68
Relación precio/flujo de caja
4.83

Illumina Inc

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

Noticias